Hybrid supercapacitors such as Lithium-ion capacitors (LICs) are one of the most modern energy storage devices of great research interest. The hybridization of the battery-type anode with the capacitive-type cathode brings out the synergic effect of enhanced energy density, power capability, long cycle life, and wide operating temperature. Herein, we introduce a simultaneous alloying-intercalation process from the recovered graphite: silicon monoxide (RG: SiO) composite as a negative electrode for the LIC applications with the activated carbon (AC) as a counter electrode.
View Article and Find Full Text PDFLithium-ion hybrid capacitors (LICs) have become promising electrochemical energy storage systems that overcome the limitations of lithium-ion batteries and electrical double-layer capacitors. The asymmetric combination of these devices enhances the overall electrochemical performance by delivering simultaneous energy and power capabilities. Lithium titanate (LiTiO, LTO), a spinel zero-strain material, has been studied extensively as an anode material for LIC applications because of its high-rate capability, negligible volume change, and enhanced cycling performance.
View Article and Find Full Text PDFThe second-generation supercapacitor comprises the hybridized energy storage mechanism of Lithium-ion batteries and electrical double-layer capacitors, i.e, Lithium-ion capacitors (LICs). The electrospun SnO nanofibers are synthesized by a simple electrospinning technique and are directly used as anode material for LICs with activated carbon (AC) as a cathode.
View Article and Find Full Text PDFThe advantage of hybridizing battery and supercapacitor electrodes has succeeded recently in designing hybrid charge storage systems such as lithium-ion capacitors (LICs) with the benefits of higher energy than supercapacitors and more power density than batteries. However, sluggish Li-ion diffusion of battery anode is one of the main barriers and hampers the development of high-performance LICs. Herein, is introduced a new conversion/displacement type anode, MnCO , via effectively recycling spent Li-ion batteries cathodes for LICs applications.
View Article and Find Full Text PDFSpent lithium-ion batteries (LIBs) offer immense potential in the form of resources such as Li, transition metals (Co, Ni, and Mn), graphite, and Cu, which can be recovered through suitable recycling procedures. The Cu-current collector is recovered from spent LIBs and converted as a copper oxide (CuO) anode for Na-ion batteries. The performance of CuO is evaluated with carboxymethyl cellulose (CMC) (CuO-C), and polyvinylidene fluoride (PVdF) (CuO-P) binders in CuO half-cell and CuO/carbon-coated Na V (PO ) O F (CuO/NVPOF) full-cell assemblies.
View Article and Find Full Text PDFNew antibiotic options are needed for the treatment of multidrug-resistant (MDR) infections. We present a case of a man aged 64 years with a bladder fistula due to radiation, ultimately causing osteomyelitis of the pubic symphysis. Repeated antibiotic courses, without correcting the fistula, resulted in infection with MDR He was successfully treated for his osteomyelitis through cystectomy, aggressive debridement and a prolonged course of antimicrobials directed at the MDR isolate.
View Article and Find Full Text PDFIdentification and validation is the first phase of target-based antimicrobial development. BfmR (RstA), a response regulator in a two-component signal transduction system (TCS) in Acinetobacter baumannii, is an intriguing potential antimicrobial target. A unique characteristic of BfmR is that its inhibition would have the dual benefit of significantly decreasing in vivo survival and increasing sensitivity to selected antimicrobials.
View Article and Find Full Text PDFPassive immunotherapy for established infections, as opposed to active immunization to prevent disease, remains a tiny niche in the world of antimicrobial therapies. Many of the passive immunotherapies currently available are directed against bacterial toxins, such as botulism, or are intended for agents of bioterrorism such as anthrax, which fortunately has remained rare. The emergence of Ebola virus and multi-drug resistant pathogens, however, may breathe new life into the immunotherapy field as researchers seek non-antibiotic interventions for infectious diseases.
View Article and Find Full Text PDF